Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Int J Cardiol ; 249: 313-318, 2017 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-29121732

RESUMO

AIMS: LIVE:LIFE is a multi-centre, open-label, prospective observational cohort study assessing health-related quality of life (HRQoL) in older patients with chronic heart failure (CHF) following initiation of ivabradine. The primary endpoint is change in Minnesota Living with Heart Failure Questionnaire (MLWHFQ) total score after 6months. METHODS AND RESULTS: Consenting patients aged ≥70years with CHF, in whom ivabradine was initiated within its licensed indication, were enrolled. Demographic, clinical and HRQoL (MLWHFQ, SF-12) data were collected at baseline (V1), 2 (V2) and 6months (V3). Over 14months, 240 patients were recruited from 44 UK centres. Ninety-nine (41%) were female and 28% aged ≥80years. Aetiology was ischaemic in 152 (63%) and 59% had been diagnosed with CHF for ≤2yrs. 52% of patients were New York Heart Association (NYHA) Class III and 57% had left ventricular ejection fraction <35%. 57% received beta-blockers. Patients had multiple comorbidities (144 (60%) hypertension, 105 (44%) asthma/COPD, 80 (33%) diabetes) and were prescribed a mean of 9±3 daily medications. Resting heart rate was 83bpm at baseline and fell 13bpm by V3. In patients completing both visits (n=187), comparing V3 to baseline: MLWHFQ total score improved by 9 points (p<0.0001, 95% CI: 7-12); 30% of patients improved ≥1 NYHA class and global assessment improved from patient (59%) and physician (60%) perspectives. 88% of patients completing V3 were still taking ivabradine. CONCLUSIONS: These contemporary prospective UK data demonstrate improvements in HRQoL and functional status with ivabradine therapy in typical older CHF patients. Despite comorbidities and polypharmacy, ivabradine was well tolerated.


Assuntos
Benzazepinas/uso terapêutico , Fármacos Cardiovasculares/uso terapêutico , Insuficiência Cardíaca/tratamento farmacológico , Insuficiência Cardíaca/epidemiologia , Qualidade de Vida , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Seguimentos , Insuficiência Cardíaca/psicologia , Humanos , Ivabradina , Masculino , Estudos Prospectivos , Qualidade de Vida/psicologia , Inquéritos e Questionários , Resultado do Tratamento , Reino Unido/epidemiologia
2.
Neurology ; 67(12): 2147-53, 2006 Dec 26.
Artigo em Inglês | MEDLINE | ID: mdl-17082466

RESUMO

OBJECTIVE: To determine factors predictive of long-term seizure outcome in children with new-onset temporal lobe epilepsy (TLE). METHODS: A community-based cohort of 77 children with new-onset TLE, including 14 with possible TLE, were followed prospectively with formal review 7 and 14 years following seizure onset. Diagnoses were re-evaluated at each review, and changed when new clinical, EEG, or imaging data were compelling. RESULTS: Sixty-four patients sustained the diagnosis of TLE over time; two were lost to follow-up. Age at follow-up was 12 to 29 years (median 20 years). Median follow-up was 13.7 years, 95% being followed for greater than 10 years. Nineteen patients were seizure free (SF) and off treatment, having not had seizures for 5 to 15 years. Duration of active TLE in the SF group was 1 to 8 years, the children being treated with 0 to 3 antiepileptic drugs (AEDs). Forty-three patients were not seizure free (NSF) and had ongoing seizures or had undergone epilepsy surgery. These children were treated with 1 to 10 AEDs. Fifteen NSF patients experienced 22 nonterminal seizure remissions of 1 to 7 years duration. Seventeen children had a significant antecedent to TLE. Lesions were identified on neuroimaging in 28 and included hippocampal sclerosis (HS) in 10, tumor in 8, and dysplasia in 7. All children with lesions on MRI were NSF (p < 0.001). Focal slowing on EEG was also associated with persistent seizures (p = 0.05), although this was correlated with a lesion on MRI. Infantile onset of epilepsy, family history of seizures, initial seizure frequency, antecedents, and early seizure remissions were not predictive of seizure outcome. CONCLUSION: Seizures spontaneously remit in approximately one third of children with new-onset TLE. A lesion on MRI predicts intractable seizures in TLE and the potential need for epilepsy surgery.


Assuntos
Anticonvulsivantes/uso terapêutico , Epilepsia do Lobo Temporal/diagnóstico , Epilepsia do Lobo Temporal/tratamento farmacológico , Imageamento por Ressonância Magnética/métodos , Avaliação de Resultados em Cuidados de Saúde/métodos , Adolescente , Austrália/epidemiologia , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Estudos de Coortes , Epilepsia do Lobo Temporal/epidemiologia , Feminino , Humanos , Lactente , Estudos Longitudinais , Imageamento por Ressonância Magnética/estatística & dados numéricos , Masculino , Prognóstico , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Resultado do Tratamento
3.
J Biol Chem ; 275(21): 16373-81, 2000 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-10748205

RESUMO

C/EBPalpha, beta, and delta are all expressed by bone marrow-derived macrophages. Ectopic expression of any of these transcription factors is sufficient to confer lipopolysaccharide (LPS)-inducible expression of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) to a B lymphoblast cell line, which normally lacks C/EBP factors and does not display LPS induction of proinflammatory cytokines. Thus, the activities of C/EBPalpha, beta, and delta are redundant in regard to expression of IL-6 and MCP-1. Surprisingly, the bZIP region of C/EBPbeta, which lacks any previously described activation domains, can also confer LPS-inducible expression of IL-6 and MCP-1 in stable transfectants. Transient transfections reveal that the bZIP regions of C/EBPbeta, C/EBPdelta, and, to a lesser extent, C/EBPalpha can activate the IL-6 promoter and augment its induction by LPS. Furthermore, the transdominant inhibitor, LIP, can activate expression from the IL-6 promoter. The ability of the C/EBPbeta bZIP region to activate the IL-6 promoter in transient transfections is completely dependent upon an intact NF-kappaB-binding site, supporting a model where the bZIP protein primarily functions to augment the activity of NF-kappaB. Replacement of the leucine zipper of C/EBPbeta with that of GCN4 yields a chimeric protein that can dimerize and specifically bind to a C/EBP consensus sequence, but shows a markedly reduced ability to activate IL-6 and MCP-1 expression. These results implicate the leucine zipper domain in some function other than dimerization with known C/EBP family members, and suggest that C/EBP redundancy in regulating cytokine expression may result from their highly related bZIP regions.


Assuntos
Quimiocina CCL2/biossíntese , Proteínas de Ligação a DNA/metabolismo , Interleucina-6/biossíntese , Zíper de Leucina/genética , Lipopolissacarídeos/farmacologia , Proteínas Nucleares/metabolismo , Proteínas de Saccharomyces cerevisiae , Fatores de Transcrição/metabolismo , Animais , Linfócitos B , Sítios de Ligação , Proteína beta Intensificadora de Ligação a CCAAT , Proteínas Estimuladoras de Ligação a CCAAT , Linhagem Celular , Quimiocina CCL2/genética , Proteínas de Ligação a DNA/genética , Dimerização , Proteínas Fúngicas/genética , Regulação da Expressão Gênica , Interleucina-6/genética , Camundongos , NF-kappa B/metabolismo , Proteínas Nucleares/análise , Proteínas Nucleares/genética , Regiões Promotoras Genéticas , Isoformas de Proteínas/metabolismo , Proteínas Quinases/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Repressoras/farmacologia , Fatores de Transcrição/genética , Ativação Transcricional , Transfecção
4.
Free Radic Res ; 31(6): 631-40, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10630686

RESUMO

In the present in vitro and in vivo study we investigated the pro-oxidant effects of hemoglobin, as well as the antioxidant effects of its metabolites, in the brain. Incubation of rat brain homogenates with hemoglobin (0-10 microM) but not hemin induced lipid peroxidation up to 24 h (EC50 = 1.2 microM). Hemoglobin's effects were similar to ferrous ion (EC50 = 1.7 microM) and were blocked by the chelating agent deferoxamine (IC50 0.5 microM) and a nitric oxide-releasing compound S-nitrosoglutathione (IC50 = 40 microM). However, metabolites of hemoglobin - biliverdin and bilirubin - inhibited brain lipid peroxidation induced by cell disruption and hemoglobin (biliverdin IC50 = 12-30 and bilirubin IC50 = 75-170 microM). Biliverdin's antioxidative effects in spontaneous and iron-evoked lipid peroxidation were further augmented by manganese (2 microM) since manganese is an antioxidative transition metal and conjugates with bile pigments. Intrastriatal infusion of hemoglobin (0-24 nmol) produced slight, but significant 20-22% decreases in striatal dopamine levels. Whereas, intrastriatal infusion of ferrous citrate (0-24 nmol) dose-dependently induced a greater 66% depletion of striatal dopamine which was preceded by an acute increase of lipid peroxidation. In conclusion, contrary to the in vitro results hemoglobin is far less neurotoxic than ferrous ions in the brain. It is speculated that hemoglobin may be partially detoxified by heme oxygenase and biliverdin reductase to its antioxidative metabolites in the brain. However, in head trauma and stroke, massive bleeding could significantly produce iron-mediated oxidative stress and neurodegeneration which could be minimized by endogenous antioxidants such as biliverdin, bilirubin, manganese and S-nitrosoglutathione.


Assuntos
Pigmentos Biliares/metabolismo , Encéfalo/metabolismo , Glutationa/análogos & derivados , Hemoglobinas/metabolismo , Ferro/metabolismo , Manganês/metabolismo , Compostos Nitrosos/metabolismo , Estresse Oxidativo/fisiologia , Animais , Antioxidantes/metabolismo , Pigmentos Biliares/farmacologia , Bilirrubina/metabolismo , Bilirrubina/farmacologia , Biliverdina/metabolismo , Biliverdina/farmacologia , Encéfalo/citologia , Encéfalo/efeitos dos fármacos , Ácido Cítrico , Desferroxamina/farmacologia , Compostos Ferrosos/farmacologia , Glutationa/metabolismo , Glutationa/farmacologia , Hemoglobinas/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Manganês/farmacologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Compostos Nitrosos/farmacologia , Oxidantes/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , S-Nitrosoglutationa , Extratos de Tecidos/metabolismo
5.
Clin Nurs Res ; 3(1): 57-68, 1994 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8167578

RESUMO

The purpose of this investigation was to attempt to replicate the findings of a study by Carr and Powers (1986) which examined differences between patient and nurse perceptions of the severity of stressfulness associated with hospital- and illness-related stressors. The samples consisted of 24 patients who experienced coronary bypass surgery and 24 nurses who cared for them during their hospitalization. All participants responded to the Stressor Scale developed by Carr and Powers (1986) specifically for patients undergoing coronary bypass surgery. Findings indicated that the major findings of the original study were replicated. Three one-way analysis of variance statistical procedures indicated that cardiothoracic nurses rated all stressors and hospital-related and illness-related stressors as statistically significantly more stressful for coronary bypass patients than did the patients themselves.


Assuntos
Atitude do Pessoal de Saúde , Atitude Frente a Saúde , Ponte de Artéria Coronária/psicologia , Avaliação em Enfermagem , Recursos Humanos de Enfermagem Hospitalar/psicologia , Estresse Psicológico/enfermagem , Estresse Psicológico/psicologia , Adulto , Idoso , Ponte de Artéria Coronária/enfermagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pesquisa em Avaliação de Enfermagem , Índice de Gravidade de Doença , Estresse Psicológico/diagnóstico
6.
J Infect Dis ; 169(1): 214-7, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8277186

RESUMO

The safety, tolerability, and pharmacokinetic profile of murine monoclonal antibody to human tumor necrosis factor-alpha (TNF alpha MAb) were evaluated in 20 uninfected patients at risk of sepsis and 16 septic patients. TNF alpha MAb was well tolerated in all patients, with no immediate or delayed signs of allergic reaction. During the 28-day evaluation, side effects included thrombocytosis (11), hepatic enzyme elevations (8), cardiac arrhythmias (3), and deaths (5). Each was attributed to the patient's severe underlying disease and not to TNF alpha MAb; however, a relationship between TNF alpha MAb and these events cannot be ruled out. The half-life was 52 h for a single infusion of TNF alpha MAb. Human antibody against TNF alpha MAb was observed in 13 (76.5%) of 17 phase IA patients and 10 of 10 phase IB patients and anti-idiotype antibodies in 11 (91.7%) of 12 phase IA patients and 2 (33.3%) of 6 phase IB patients. TNF alpha MAb should be evaluated as adjunctive therapy for patients with sepsis.


Assuntos
Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais/metabolismo , Imunoglobulina G/efeitos adversos , Imunoglobulina G/metabolismo , Fator de Necrose Tumoral alfa/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais/uso terapêutico , Relação Dose-Resposta a Droga , Feminino , Seguimentos , Meia-Vida , Humanos , Imunoglobulina G/administração & dosagem , Imunoglobulina G/uso terapêutico , Infusões Intravenosas , Interleucina-1/sangue , Masculino , Taxa de Depuração Metabólica , Camundongos , Pessoa de Meia-Idade , Choque Séptico/sangue , Choque Séptico/tratamento farmacológico , Fator de Necrose Tumoral alfa/biossíntese
7.
Heart Lung ; 21(4): 342-9, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1629003

RESUMO

This study examined the self-reported sleep patterns of adult patients undergoing coronary artery bypass graft (CABG) surgery and the relationship between their perceived illness-related stress and sleep disturbances. Twenty-four patients completed data at all three collection points: preadmission, and the third and sixth postoperative mornings. Patients responded to the Verran/Snyder-Halpern Sleep Scale and the Carr and Powers Stressor Scale for patients having CABG. By use of a within-subject, one-factor, repeated measures analysis of variance, statistically significant differences were found in each of the three sleep dimensions measured over time (disturbance, effectiveness, and supplementation). With the Pearson correlation, the hypothesis that sleep disturbances in patients having open-heart surgery are related to psychologic stress associated with illness was not supported. Additional analyses indicated that hospital and illness-related stress, duration of cardiopulmonary bypass, anesthesia time, and sleep medication were related to patients' sleep disturbance, effectiveness, or supplementation in different ways and at different times during the study periods.


Assuntos
Ponte de Artéria Coronária/psicologia , Transtornos do Sono-Vigília/psicologia , Estresse Psicológico/fisiopatologia , Análise de Variância , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório , Fases do Sono , Transtornos do Sono-Vigília/epidemiologia
8.
Aust J Public Health ; 16(1): 50-7, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1627712

RESUMO

Three drug use surveys employing a standardised questionnaire format and sampling procedure were conducted on samples of New South Wales school students in 1983, 1986 and 1989. Alcohol and tobacco were the most frequently used substances across the surveys, with rates of use of illicit substances being considerably lower. Declines in the prevalence of alcohol, tobacco and stimulant use were found between 1983 and 1986 and between 1986 and 1989 for both males and females. Rates of use of inhalants, sedatives, hallucinogens and narcotics declined between 1983 and 1986, but remained unchanged between the 1986 and 1989 samples. Cannabis use declined significantly among females between 1983 and 1989, but not among males. Possible reasons for the general decline in drug use over the six-year period are discussed.


Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Drogas Ilícitas , Fumar/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Austrália/epidemiologia , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Prevalência , Fatores Sexuais
9.
Aust J Public Health ; 16(1): 43-9, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1627711

RESUMO

This paper presents findings on drug prevalences for licit and illicit drugs among New South Wales secondary school students (n = 3753) in late 1989. It also considers the accuracy of students' perceptions of the drug causing the most and fewest drug-related deaths. Data were analysed by age and gender, using logistic regression for the prevalence data. Findings indicate that licit drugs (tobacco, alcohol and analgesics) were the most frequently and widely used. Rates for illicit drugs were low, although there was some degree of experimental use of cannabis which increased amongst older males. Perceptions were found to be inaccurate in emphasising the dangers of the illicit drug heroin over those of the licit drugs tobacco and alcohol. Reasons for these findings are discussed, and more in-depth research recommended into the relationship between drug prevalences and perceptions for different age groups, and its relevance for planning drug prevention initiatives.


Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Drogas Ilícitas , Fumar/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Adulto , Austrália/epidemiologia , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Prevalência , Transtornos Relacionados ao Uso de Substâncias/mortalidade , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle
10.
Clin Immunol Immunopathol ; 62(1 Pt 2): S11-7, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1370262

RESUMO

There is an increasing incidence of sepsis among hospitalized patients. Also, high mortality associated with sepsis and septic shock persists despite appropriate antibiotic therapy. Recent investigations have demonstrated that bacterial antigens stimulate a cascade of cellular mediators or cytokine release. In sepsis and septic shock the response of these cytokines often exceeds natural downregulation and leads to multisystem organ failure and even death in an unacceptably high number of patients. Many investigative studies have shown that tumor necrosis factor (TNF) is the prime mediator of the inflammatory response seen in sepsis and septic shock. Sepsis management in the future will include immune modulating therapy directed against the deleterious effects of cytokines, specifically TNF. This article reviews the current problem of sepsis and the evidence to support the role of TNF in sepsis. also, recent studies employing monoclonal antibodies against TNF as well as considerations for future studies are discussed.


Assuntos
Sepse/etiologia , Fator de Necrose Tumoral alfa/fisiologia , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/uso terapêutico , Ensaios Clínicos como Assunto , Humanos , Interferons/fisiologia , Interleucina-1/fisiologia , Lipopolissacarídeos , Sepse/terapia , Fator de Necrose Tumoral alfa/imunologia
11.
Semin Cancer Biol ; 1(4): 257-63, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2103500

RESUMO

The growth regulatory functions of a family of structurally related polypeptides are mediated through the membrane-bound epidermal growth factor receptor molecule. This ligand family includes epidermal growth factor, transforming growth factor-alpha, amphiregulin, and polypeptides encoded by several poxviruses. The structural and functional properties that are characteristic of the ligand family provide a basis for possible evolutionary relationships among the various ligands.


Assuntos
Receptores ErbB/fisiologia , Substâncias de Crescimento/fisiologia , Peptídeos e Proteínas de Sinalização Intercelular , Sequência de Aminoácidos , Anfirregulina , Animais , Família de Proteínas EGF , Fator de Crescimento Epidérmico/metabolismo , Fator de Crescimento Epidérmico/fisiologia , Receptores ErbB/metabolismo , Glicoproteínas/metabolismo , Glicoproteínas/fisiologia , Substâncias de Crescimento/metabolismo , Humanos , Ligantes , Dados de Sequência Molecular , Fator de Crescimento Transformador alfa/metabolismo , Fator de Crescimento Transformador alfa/fisiologia , Proteínas Virais/metabolismo
12.
J Immunol ; 135(3): 1819-25, 1985 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3160781

RESUMO

The p220 antigen is found on the high m.w. form of the T200 common leukocyte antigen family. Although T200 monoclonal antibodies (MAb) react with all hematopoietic cells, p220 MAb react only with B cells, NK cells, about 50% of CD4+ T helper cells, and about 90% of CD8+ T suppressor cells. The p220 antigen appears to play an important role in T cell activation, because anti-p220 MAb at doses as low as 5 ng/ml accelerate the proliferation kinetics of PHA-stimulated T cells and augment anti-CD3-driven proliferation when IL 2 is in excess. Fab fragments have no effect on PHA-stimulated cells but partially block proliferation in response to anti-CD3. Our data suggest that p220 is functionally related to expression of the IL 2 receptor. Anti-p220 MAb cause an increase in the number of T cells that express the IL 2 receptor early after activation. In addition, T cells begin to turn off expression of p220 after activation, and two-color immunofluorescence shows that by day 3 after activation the cells expressing the most IL 2 receptor have the least p220. The loss of p220 on T cells may reflect a post-thymic differentiation process related to cell activation. Our data are consistent with a model where the p220- T cells in peripheral blood are a more activated population of T cells that have lost p220 and its ability to regulate their IL 2 receptor expression.


Assuntos
Antígenos de Histocompatibilidade/imunologia , Isoanticorpos/imunologia , Receptores Imunológicos/imunologia , Linfócitos T/imunologia , Antígenos de Diferenciação de Linfócitos T , Antígenos de Superfície/imunologia , Humanos , Antígenos Comuns de Leucócito , Leucócitos/imunologia , Ativação Linfocitária , Fito-Hemaglutininas/farmacologia , Receptores de Antígenos de Linfócitos T/imunologia , Receptores de Interleucina-2 , Linfócitos T/classificação , Linfócitos T/citologia
14.
Ann N Y Acad Sci ; 330: 673-86, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-294214

RESUMO

Four samples of cummingtonite-grunerite series in various crystallization habits were tested in vitro. The cytotoxicity to Chinese hamster ovary cells and hemolysis to sheep erythrocytes were inversely proportional to the structural faults and surface defects of the minerals. At a comparable surface area, asbestiform grunerite (UICC amosite), semi-asbestiform cummingtonite, acicular cummingtonite, and acicular grunerite were found to be cytotoxic and hemolytic in a decreasing order. The influence of particle size on hemolysis and cytotoxicity was observed with acicular grunerite. Although samples of relatively large particle size were found to be inert, samples of smaller particle size were cytotoxic as well as hemolytic. No apparent relationship between surface charge and hemolysis as well as cytotoxicity was observed.


Assuntos
Amianto/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Minerais/toxicidade , Animais , Linhagem Celular , Cricetinae , Cristalização , Eritrócitos/efeitos dos fármacos , Feminino , Hemólise/efeitos dos fármacos , Técnicas In Vitro , Ovário , Tamanho da Partícula , Ovinos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA